feglymycin: isolated from Streptomyces; structure in first source
ID Source | ID |
---|---|
PubMed CID | 25256761 |
MeSH ID | M0333255 |
Synonym |
---|
feglymycin |
feglymicin (compound 30) |
bdbm119091 |
209335-49-9 |
(2r)-2-(4-hydroxyphenyl)glycyl-(2r)-2-(3,5-dihydroxyphenyl)glycyl-l-valyl-(2r)-2-(3,5-dihydroxyphenyl)glycyl-(2s)-2-(4-hydroxyphenyl)glycyl-(2r)-2-(3,5-dihydroxyphenyl)glycyl-(2s)-2-(4-hydroxyphenyl)glycyl-(2r)-2-(3,5-dihydroxyphenyl)glycyl-l-valyl-(2r)-2 |
AKOS040756092 |
Feglymycin is a naturally occurring, anti-HIV and antimicrobial 13-mer peptide. It includes highly racemizable 3,5-dihydroxyphenylglycines (Dpgs)
Excerpt | Reference | Relevance |
---|---|---|
"Feglymycin is a naturally occurring, anti-HIV and antimicrobial 13-mer peptide that includes highly racemizable 3,5-dihydroxyphenylglycines (Dpgs). " | ( Total synthesis of feglymycin based on a linear/convergent hybrid approach using micro-flow amide bond formation. Fuse, S; Mifune, Y; Nakamura, H; Tanaka, H, 2016) | 2.21 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 2 (20.00) | 29.6817 |
2010's | 6 (60.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (22.00) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 10 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |